Clinical Trial Update: The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors [Phase 2]

View source ↗

Summary

Phase 2 study conducted by the National Cancer Institute evaluating treatments for grade I soft tissue sarcomas and benign, non-metastasizing highly invasive so…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma, Neoplasms | Phase 2 | Status: COMPLETED